May 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2021 Mar 31, 2020 Mar 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 14.31 18.37 15.20
(-22.1 pct) (-4.6 pct)
Operating 226 mln 2.00 670 mln
(-88.6 pct) (-35.4 pct)
Recurring 250 mln 1.98 670 mln
(-87.3 pct) (-36.3 pct)
Net
Net 216 mln 1.31 540 mln
(-83.5 pct) (-37.1 pct)
EPS 57.23 yen 339.36 yen 142.80 yen
Ann Div 40.00 yen 40.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T